117 related articles for article (PubMed ID: 11070238)
1. Effect of the monocyte locomotion inhibitory factor (MLIF) produced by Entamoeba histolytica on the expression of cell adhesion molecules (CAMs) in the skin of guinea pigs.
Giménez-Scherer JA; Arenas E; Díaz L; Rico G; Fernández J; Kretschmer R
Arch Med Res; 2000; 31(4 Suppl):S92-3. PubMed ID: 11070238
[No Abstract] [Full Text] [Related]
2. Inhibition of contact cutaneous delayed hypersensitivity reactions to DNBC in guinea pigs by the monocyte locomotion inhibitory factor (MLIF) produced by axenically grown Entamoeba histolytica.
Giménez Scherer JA; Rico G; Fernández-Diez J; Kretschmer RR
Arch Med Res; 1997; 28 Spec No():237-8. PubMed ID: 9033085
[No Abstract] [Full Text] [Related]
3. Entamoeba dispar does not produce the monocyte locomotion inhibitory factor (MLIF) produced by Entamoeba histolytica.
Silva García R; Rico Rosillo G; Espinosa Cantellano M; Castañon G; Giménez Scherer J; Kretschmer R
Parasite Immunol; 2003 Feb; 25(2):99-101. PubMed ID: 12791105
[No Abstract] [Full Text] [Related]
4. The effect of the monocyte locomotion inhibitory factor (MLIF) produced by Entamoeba histolytica upon nitric oxide production by human leukocytes.
Rico G; Leandro E; Rojas S; Giménez J; Kretschmer R
Arch Med Res; 2000; 31(4 Suppl):S90-1. PubMed ID: 11070237
[No Abstract] [Full Text] [Related]
5. Induction of protective immunity against experimental amebic abscess of the liver (EAAL) using the monocyte locomotion inhibitory factor (MLIF) produced by Entamoeba histolytica: a preliminary report.
López-Osuna M; Cárdenas G; Isario J; Arellano J; Fernández-Diez J; Isibasi A; Kretschmer R
Arch Med Res; 2000; 31(4 Suppl):S110-1. PubMed ID: 11070246
[No Abstract] [Full Text] [Related]
6. Could the homologous sequence of anti-inflammatory pentapeptide (MLIF) produced by Entamoeba histolytica in the N protein of rabies virus affect the inflammatory process?
Morales ME; Rico G; Gómez JL; Alonso R; Cortés R; Silva R; Giménez JA; Kretschmer R; Aguilar-Setién A
Parasitol Res; 2006 Feb; 98(3):232-6. PubMed ID: 16341883
[TBL] [Abstract][Full Text] [Related]
7. Isolation and structural studies of the monocyte locomotion inhibitory factor (MLIF) produced by Entamoeba histolytica.
Kretschmer R; Rico G; Giménez JA
Arch Med Res; 2000; 31(4 Suppl):S76-7. PubMed ID: 11070231
[No Abstract] [Full Text] [Related]
8. The monocyte locomotion inhibitory factor an anti-inflammatory peptide; therapeutics originating from amebic abscess of the liver.
Velazquez JR
Recent Pat Endocr Metab Immune Drug Discov; 2011 Jan; 5(1):7-12. PubMed ID: 22074573
[TBL] [Abstract][Full Text] [Related]
9. A novel anti-inflammatory oligopeptide produced by Entamoeba histolytica.
Kretschmer RR; Rico G; Giménez JA
Mol Biochem Parasitol; 2001 Feb; 112(2):201-9. PubMed ID: 11223127
[TBL] [Abstract][Full Text] [Related]
10. The role of mannose in the receptor of the monocyte locomotion inhibitory factor produced by Entamoeba histolytica.
Kretschmer RR; Castro EM; Pacheco G; Rico G; Díaz-Guerra O; Arellano J
Parasitol Res; 1991; 77(5):374-8. PubMed ID: 1653955
[TBL] [Abstract][Full Text] [Related]
11. The monocyte locomotion inhibitory factor (MLIF) produced by axenically grown Entamoeba histolytica fails to affect the locomotion and the respiratory burst of human eosinophils in vitro.
Rico G; Kretschmer RR
Arch Med Res; 1997; 28 Spec No():233-4. PubMed ID: 9033083
[No Abstract] [Full Text] [Related]
12. Ultrastructural changes associated with the inhibition of monocyte chemotaxis caused by products of axenically grown Entamoeba histolytica.
Giménez-Scherer JA; Pacheco-Cano MG; Cruz de Lavín E; Hernández-Jáuregui P; Merchant MT; Kretschmer RR
Lab Invest; 1987 Jul; 57(1):45-51. PubMed ID: 2885445
[TBL] [Abstract][Full Text] [Related]
13. Cytokine expression in CD4(+) cells exposed to the monocyte locomotion inhibitory factor produced by Entamoeba histolytica.
Rojas-Dotor S; Rico G; Pérez J; Velázquez J; Silva R; Morales E; Kretschmer R
Parasitol Res; 2006 Apr; 98(5):493-5. PubMed ID: 16374615
[TBL] [Abstract][Full Text] [Related]
14. Production of the monocyte locomotion inhibitory factor (MLIF) by axenically grown Entamoeba histolytica: synthesis or degradation?
Rico G; Ximénez C; Ramos F; Kretschmer RR
Arch Med Res; 1997; 28 Spec No():235-6. PubMed ID: 9033084
[No Abstract] [Full Text] [Related]
15. Further physicochemical characterization of the monocyte locomotion inhibition factor (MLIF) produced by Entamoeba histolytica.
Díaz-Guerra O; Rico G; Ladrón de Guevara O; Padilla P; García L; Kretschmer RR
Arch Med Res; 1992; 23(2):151-2. PubMed ID: 1340280
[TBL] [Abstract][Full Text] [Related]
16. Effect of the monocyte locomotion inhibitory factor (MLIF) produced by Entamoeba histolytica upon the respiratory burst of human leukocytes.
Rico G; Díaz-Guerra O; Giménez-Scherer JA; Kretschmer RR
Arch Med Res; 1992; 23(2):157-9. PubMed ID: 1340282
[TBL] [Abstract][Full Text] [Related]
17. The Cys-Asn-Ser carboxyl-terminal end group is the pharmacophore of the amebic anti-inflammatory monocyte locomotion inhibitory factor (MLIF).
Morales-Martínez ME; Silva-García R; Soriano-Correa C; Giménez-Scherer JA; Rojas-Dotor S; Blanco-Favela F; Rico-Rosillo G
Mol Biochem Parasitol; 2008 Mar; 158(1):46-51. PubMed ID: 18180049
[TBL] [Abstract][Full Text] [Related]
18. Does Entamoeba dispar produce monocyte locomotion inhibitory factor (MLIF) like Entamoeba histolytica?
Silva R; Rico G; Espinosa-Cantellano M; Giménez JA; Kretschmer R
Arch Med Res; 2000; 31(4 Suppl):S94-5. PubMed ID: 11070239
[No Abstract] [Full Text] [Related]
19. Pro and Anti-inflammatory Cytokine Production in CD4+ T Lymphocytes in Children with Asthma and Allergic Rhinitis Exposed to the Monocyte Locomotion Inhibitory Factor (MLIF).
Rojas-Dotor S; González-Hernández A; León-Aguilar FH; Juárez-Téllez V; Gómez de León Cruces P
Iran J Allergy Asthma Immunol; 2018 Aug; 17(4):388-392. PubMed ID: 30537802
[TBL] [Abstract][Full Text] [Related]
20. The effect of an anti-inflammatory pentapeptide produced by Entamoeba histolytica on gene expression in the U-937 monocytic cell line.
Silva-García R; Estrada-García I; Ramos-Payán R; Torres-Salazar A; Morales-Martínez ME; Arenas-Aranda D; Giménez-Scherer JA; Blanco-Favela F; Rico-Rosillo MG
Inflamm Res; 2008 Apr; 57(4):145-50. PubMed ID: 18368290
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
